The U.S. has its first new sunscreen active ingredient in more than 25 years: bemotrizinol, also known as BEMT. The FDA approved the ingredient in June, and the first products containing it are now appearing on U.S. store shelves, including formulations from Neutrogena and other manufacturers.

BEMT is a chemical sunscreen filter designed to provide broad-spectrum protection against both UVB rays, which cause sunburn, and UVA rays, which are linked to skin cancer risk and premature skin aging. Dermatologists and other experts say it helps fill a “market gap” by delivering dual UV protection without the white streaking or discoloration that some people associate with mineral-based sunscreens using zinc oxide and titanium dioxide. They also note BEMT has been used internationally and has long-running safety evidence.

FDA safety evaluation is based on studies in more than 500 patients that found minimal skin absorption and no irritation or allergic reactions in daily-use testing for up to three weeks. The ingredient is also described as more stable in sunlight than some earlier UVA filters. Outlets also highlight ongoing scrutiny of sunscreen ingredients’ potential environmental effects, including coral reef impacts, and emphasize that sunscreen should be part of a broader sun-protection routine.